Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus

• Published in: PloS one 2022-02, Vol.17 (2), p.e0263536-e0263536
• Main Authors: Lerkvaleekul, Butsabong, Apiwattanakul, Nopporn, Tangnararatchakit, Kanchana, Jirapattananon, Nisa, Srisala, Supanart, Vilaiyuk, Soamarat
• Format: Article
• Language: English
• Subjects: Adolescent; Age of Onset; Analysis; Anemia; Antibodies; Arthritis; Autoimmune diseases; Autoimmune hemolytic anemia; Biology and life sciences; Blood; Case-Control Studies; CD19 antigen; CD4 antigen; CD8 antigen; Cell number; Child; Chronic conditions; Cohort Studies; Diagnosis; Disease; Female; Flow Cytometry; Hemolytic anemia; Hospitals; Humans; Immunoregulation; Laboratories; Longitudinal Studies; Lupus; Lupus Erythematosus, Systemic - blood; Lupus Erythematosus, Systemic - diagnosis; Lupus Erythematosus, Systemic - epidemiology; Lupus Erythematosus, Systemic - pathology; Lupus nephritis; Lymphocyte Count; Lymphocyte Subsets - pathology; Lymphocytes; Lymphocytes B; Lymphocytes T; Male; Medicine; Medicine and health sciences; Mucosa; Natural killer cells; Nephritis; Nephrology; Pathogenesis; Patients; Pediatrics; Phenotype; Phenotypes; Prognosis; Remission; Remission (Medicine); Rheumatology; Risk factors; Severity of Illness Index; Subpopulations; Systemic lupus erythematosus; Thailand - epidemiology; Vasculitis
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0263536

Juvenile-onset systemic lupus erythematosus (JSLE) is a complex and heterogeneous immune-mediated disease. Cellular components have crucial roles in disease phenotypes and outcomes. We aimed to determine the associations of lymphocyte subsets with clinical manifestations and long-term outcomes in JSLE patients. A cohort of 60 JSLE patients provided blood samples during active disease, of whom 34 provided further samples during inactive disease. In a longitudinal study, blood samples were obtained from 49 of the JSLE patients at 0, 3, and 6 months. The healthy control (HC) group consisted of 42 age-matched children. Lymphocyte subsets were analyzed by flow cytometry. The percentages of CD4+ T, γδ T, and NK cells were significantly decreased in JSLE patients compared with HC, while the percentages of CD8+ T, NKT, and CD19+ B cells were significantly increased. The percentage of regulatory T cells (Tregs) was significantly lower in JSLE patients with lupus nephritis (LN) than in non-LN JSLE patients and HC. The patients were stratified into high and low groups by the median frequency of each lymphocyte subset. The γδ T cells high group and NK cells high group were significantly related to mucosal ulcer. The CD4+ T cells high group was significantly associated with arthritis, and the NKT cells high group was substantially linked with autoimmune hemolytic anemia. The CD8+ T cells low group was mainly related to vasculitis, and the Tregs low group was significantly associated with LN. The percentage of Tregs was significantly increased at 6 months of follow-up, and the LN JSLE group had a lower Treg percentage than the non-LN JSLE group. Predictors of remission on therapy were high Tregs, high absolute lymphocyte count, direct Coombs test positivity, and LN absence at enrollment. JSLE patients exhibited altered lymphocyte subsets, which were strongly associated with clinical phenotypes and long-term outcomes.